おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Exvastat
company
About
Exvastat is an innovative, preclinical-stage pharmaceutical company.
- 1 - 10
Highlights
Details
- Last Funding Type
- Seed
- Industries
- Biotechnology,Health Care,Life Science,Medical,Pharmaceutical
- Founded date
- Jan 1, 2016
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Exvastat is an innovative, preclinical-stage pharmaceutical company founded in 2016. The company is developing a treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications. The new treatment has the potential to significantly reduce the high mortality and incapacitating morbidities caused by ARDS, as well as the costs of caring for these critically ill patients to health service providers.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Exvastat has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Jan 1, 2017 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 1, 2017 | Seed | — | 1 |
Cambridge Innovation Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Exvastat is funded by 1 investors.
Cambridge Innovation Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Cambridge Innovation Capital
|
Yes | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
